Preferred Label : Fluorine F 18 Piflufolastat;

NCIt synonyms : 2-(3-{1-Carboxy-5-[(6-[(18)F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic Acid; Piflufolastat F-18; Fluorine F 18 DCFPyL; 18F-DCFPYL; 2-(3-(1-Carboxy-5-((6-(18f)fluoro-pyridine-3-carbonyl)-amino)-pentyl)-ureido)-pentanedioic Acid; Piflufolastat F18; Piflufolastat F 18;

NCIt definition : A urea-based radiotracer composed of the prostate specific membrane antigen (PSMA) targeting agent DCFPyL and labeled with the positron-emitting isotope, fluorine F 18, that can potentially be used for positron emitting tomography (PET) imaging. Upon administration of fluorine F piflufolastat, piflufolastat binds to PSMA expressed on tumor cells. The fluorine F 18 moiety facilitates PET imaging of PSMA-expressing tumor cells. PSMA, a cell-surface antigen, is abundantly present on the surface of prostate cancer cells and on the neovasculature of most solid tumors.;

UNII : 3934EF02T7;

CAS number : 1207181-29-0;

Drug name : Pylarify;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3498744/fr/pylclari-18f-piflufolastat-cancer-de-la-prostate
2024
false
false
false
France
adult
radiopharmaceuticals
Positron-Emission tomography
F-18 DCFPyL PSMA Positron Emission Tomography
piflufolastat (18F)
Prostate-Specific antigen
neoplasm staging
neoplasm recurrence, local
injections, intravenous
evaluation of the transparency committee
prostatic neoplasms
Fluorine F 18 Piflufolastat
Fluorine-18

---
https://www.ema.europa.eu/en/medicines/human/EPAR/pylclari
2023
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Fluorine F 18 Piflufolastat
Fluorine F 18 Piflufolastat
piflufolastat (18F)
drug approval
europe
adult
prostatic neoplasms
Positron-Emission tomography
FOLH1 protein, human
neoplasm recurrence, local
Presence of direct invasion by primary malignant neoplasm of prostate to periprostatic tissue (observable entity)
neoplasm staging
fluorine radioisotopes
fluorine radioisotopes
radiopharmaceuticals
product surveillance, postmarketing
injections, intravenous
pregnancy
breast feeding
drug evaluation, preclinical

---
https://www.has-sante.fr/jcms/p_3474603/fr/pylclari-18f-piflufolastat-cancer-de-la-prostate
2023
false
false
false
France
insurance, health, reimbursement
Fluorine F 18 Piflufolastat
piflufolastat (18F)
radiopharmaceuticals
Positron-Emission tomography
F-18 DCFPyL PSMA Positron Emission Tomography
neoplasm recurrence, local
neoplasm staging
injections, intravenous
evaluation of the transparency committee
prostatic neoplasms
Fluorine-18

---
Nous contacter.
09/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.